NFKB1 and pachyonychia congenita: For example, erlotinib and gemcitabine inhibited the growth of tumor by activating Akt and nuclear factor-κB (NF-κB) signaling pathway and resulted in an obvious improvement in the survival of advanced PC patients (23).